MethylCap-Seq has been applied to analyze methylomic patterns of ovarian tumors and results suggest that hedgehog signaling pathway members (ZIC1 and ZIC4) are DNA methylation prognostic biomarkers for ovarian cancer (68, 69). This evidence concerns the gene ZIC1 and ovarian carcinoma.